Category:
Anti-tumor Preparations
Standard:
N;
It is a modified enzyme used as an antineoplastic agent. It is a form of L-asparaginase which has undergone PEGylation. It is used in the treatment of acute lymphoblastic leukemia.
Strength: 5ml:3750IU; 2ml:1500IU
It has been approved by CFDA.
Pegaspargase Injection is a PEGylated enzyme therapeutic derived from Escherichia coli. It functions by hydrolyzing L-asparagine, depriving leukemic cells of essential amino acids required for protein synthesis and proliferation.